Delivering programs successfully, through regulatory approval.
McCowen Analytical Contract Labs
With over 30 years in regulated bioanalytical research and development labs, we know what you need to successfully get your program from early phase discovery to commercialization.
We currently work with companies as small as 2 people with an idea and as large as multi-million dollar enterprises with products already in commercialization.
Because we’re small we can cut out some of the internal red-tape to move projects quickly to enhance your speed to market, potentially saving you tens to hundreds of thousands of dollars over the course of a program.
Owner: Kevin McCowen
Mr. McCowen has worked in a variety of regulatory environments, ranging from early phase discovery to GMP Analytical Development and Quality Control. McCowen has experience in a wide range of bioanalytical techniques and instrumentation platforms. He has also worked extensively with regulatory groups to deliver programs successfully through regulatory approval. He knows what you need to successfully navigate the regulatory landscape and has the instrumentation background to put together analytical programs to ensure your success.
Business Advisor: Christopher A. Rhodes, Ph.D.
Dr. Chris Rhodes is a pharmaceutical executive with three decades of experience in drug product development of complex formulations and delivery systems. Dr. Rhodes is founder and CEO of Baywind Bioventures, as well as founder and chief scientist of CASS Pharmaceuticals and Sensulin, all involved in drug delivery enabled pharmaceutical products. Dr. Rhodes founded the CDMO Drug Delivery Experts in 2014 and sold it to Pace Life Sciences in 2021. He played a key role in R&D for Byetta, Lusedra, Bydureon, Myalept, and Afrezza and was drug development team leader for several pharmaceutical products. He has a PhD in chemistry (UCLA), a BS in chemistry (NYU), and was a Post Doc at Yale.